Sheets Smith Wealth Management Repligen Corp Transaction History

Sheets Smith Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 28, 2020	SELL	$84.96 - $109.14 $529,640 - $680,378	-6,234 Closed	0 $0
Q4 2019 Jan 24, 2020	SELL	$73.84 - $93.08 $20,675 - $26,062	-280 Reduced 4.3%	6,234 $572,000
Q3 2019 Oct 28, 2019	BUY	$76.65 - $95.51 $10,807 - $13,466	141 Added 2.21%	6,514 $500,000
Q2 2019 Jul 12, 2019	BUY	$54.2 - $85.95 $345,416 - $547,759	6,373 New	6,373 $548,000

489

54.3M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.32B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Sheets Smith Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Sheets Smith Wealth Management with notifications on news.